Japan's life insurers have increasingly relied on reinsurance in recent years, with the overall cession rate as a percentage of total gross premium written for the segment rising to more than 24% in ...
This year marks the 70th anniversary of China-Africa relations. CGTN has published an article highlighting Africa's priority role in China's overall foreign policy ...
SHENZHEN, China, May 31, 2026 /PRNewswire/ -- MARSTEK, the Global TOP-Tier Plug-in Battery Brand, today welcomed more than 100 distributors, partners, media representatives, and industry guests from ...
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced results from the final analysis of the Phase 3 PROTEUS study, evaluating apalutamide plus hormone therapy (androgen deprivation therapy, ADT ...
WEST PALM BEACH, FL / ACCESS Newswire / May 30, 2026 / Elektros Inc. (OTC PINK:ELEK) is pleased to provide shareholders with an update regarding the Company's intellectual property initiatives surroun ...
ELEK WEST PALM BEACH, FL / ACCESS Newswire / May 30, 2026 / Elektros Inc. (OTC PINK:ELEK) is pleased to provide shareholders with an update regarding the ...
WEST PALM BEACH, FL / ACCESS Newswire / May 30, 2026 / Elektros Inc. (OTC PINK:ELEK) is pleased to provide shareholders with an update regarding the Company's intellectual property initiatives surroun ...
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer across PD-L1 ...
Priyanka Chopra Jonas, Jet Li, Charles Melton, Simu Liu, Eileen Gu and Revathi Advaithi Honored Alongside the 2026 Gold100 at ...
Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...
From May 25 to 29, 2026, the 7th China-CEEC Local Leaders' Meeting and 2026 Shandong International Friendship Cities Cooperation and Exchange Week ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...